KLK14 and neoplasm: We studied KLK14 expression in 178 histologically confirmed epithelial breast carcinomas by quantitative reverse transcription–polymerase chain reaction and correlated with clinicopathological variables (tumour stage, grade, histotype etc.)and with outcome (disease-free survival and overall survival), monitored over a median of 76 months.